Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Anitua, 1999, Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants, Int J Oral Maxillofac Implants, 14, 529
Anitua, 2001, The use of plasma-rich growth factors (PRGF) in oral surgery, Pract Proced Aesthet Dent, 13, 487
Bellows, 1986, Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations, Calcif Tissue Int, 38, 143, 10.1007/BF02556874
Bhanot, 2002, Current applications of platelet gels in facial plastic surgery, Facial Plast Surg Clin North Am, 18, 27, 10.1055/s-2002-19824
Boden, 2000, The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report, Spine, 25, 376, 10.1097/00007632-200002010-00020
Bolander, 1992, Regulation of fracture repair by growth factors, Proc Soc Exp Biol Med, 200, 165, 10.3181/00379727-200-43410A
Bowen-Pope, 1984, Platelet-derived growth factor in vivo: levels, activity, and rate of clearance, Blood, 64, 458, 10.1182/blood.V64.2.458.458
Breen, 1994, TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype, J Cell Physiol, 160, 323, 10.1002/jcp.1041600214
Canalis, 1983, Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae, Metabolism, 32, 14, 10.1016/0026-0495(83)90149-X
Canalis, 1988, Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae, Endocrinology, 122, 22, 10.1210/endo-122-1-22
Casser-Bette, 1990, Bone formation by osteoblast-like cells in a three-dimensional cell culture, Calcif Tissue Int, 46, 46, 10.1007/BF02555824
Cassiede, 1996, Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro, J Bone Miner Res, 11, 1264, 10.1002/jbmr.5650110911
Centrella, 1987, Mitogenesis in fetal rat bone cells simultaneously exposed to type beta transforming growth factor and other growth regulators, FASEB J, 1, 312, 10.1096/fasebj.1.4.3498658
Cheng, 1994, Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone, Endocrinology, 134, 277, 10.1210/en.134.1.277
Cochran, 2000, Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans, J Periodontol, 71, 1241, 10.1902/jop.2000.71.8.1241
Dallas, 2002, Proteolysis of latent transforming growth factor-beta (TGF-beta )—binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix, J Biol Chem, 277, 21352, 10.1074/jbc.M111663200
Ernst, 1987, Osteoblastlike cells in a serum-free methylcellulose medium form colonies: effects of insulin and insulinlike growth factor I, Calcif Tissue Int, 40, 27, 10.1007/BF02555725
Fromigue, 1998, Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation, J Cell Biochem, 68, 411, 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T
Froum, 2002, Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports, Int J Periodontics Restorative Dent, 22, 45
Giannobile, 1997, Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I, J Dent Res, 76, 1569, 10.1177/00220345970760090901
Goshima, 1991, Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic, Biomaterials, 12, 253, 10.1016/0142-9612(91)90209-S
Graves, 1989, The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells, Connect Tissue Res, 23, 209, 10.3109/03008208909002419
Guo, 2002, Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B, J Biol Chem, 277, 14829, 10.1074/jbc.M108180200
Hay, 1999, Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation, J Cell Biochem, 72, 81, 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N
Hock, 1988, Insulin-like growth factor I has independent effects on bone matrix formation and cell replication, Endocrinology, 122, 254, 10.1210/endo-122-1-254
Hsieh, 1998, Pulse application of platelet-derived growth factor enhances formation of a mineralizing matrix while continuous application is inhibitory, J Cell Biochem, 69, 169, 10.1002/(SICI)1097-4644(19980501)69:2<169::AID-JCB7>3.0.CO;2-Q
Joyce, 1991, Role of growth factors in fracture healing, Prog Clin Biol Res, 365, 391
Kassem, 2000, Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol, Eur J Clin Invest, 30, 429, 10.1046/j.1365-2362.2000.00645.x
Kassolis, 2000, Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series, J Periodontol, 71, 1654, 10.1902/jop.2000.71.10.1654
Kim, 2002, Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants, Int J Oral Maxillofac Implants, 17, 86
Landesberg, 2000, Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation, J Oral Maxillofac Surg, 58, 297, 10.1016/S0278-2391(00)90058-2
Lekovic, 2002, Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study, J Periodontol, 73, 198, 10.1902/jop.2002.73.2.198
Lozada, 2001, Platelet-rich plasma application in sinus graft surgery: Part I—Background and processing techniques, J Oral Implantol, 27, 38, 10.1563/1548-1336(2001)027<0038:PPAISG>2.3.CO;2
Lu, 2001, TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function, J Bone Joint Surg Am, 83-A, S82
Maeda, 2002, The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3), Calcif Tissue Int, 70, 54, 10.1007/s002230010032
Marx, 1999, Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts, 71
Marx, 1998, Platelet-rich plasma: Growth factor enhancement for bone grafts, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, 638, 10.1016/S1079-2104(98)90029-4
Merklein, 1998, [Standardized tests of bone implant surfaces with an osteoblast cell culture system. I. Orthopedic standard materials], Biomed Tech (Berl), 43, 354, 10.1515/bmte.1998.43.12.354
Park, 2000, Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration, J Control Release, 67, 385, 10.1016/S0168-3659(00)00232-7
Park, 2000, Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration, Biomaterials, 21, 153, 10.1016/S0142-9612(99)00143-X
Pfeilschifter, 1990, Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta, Endocrinology, 127, 69, 10.1210/endo-127-1-69
Rattner, 2000, Mineralization and alkaline phosphatase activity in collagen lattices populated by human osteoblasts, Calcif Tissue Int, 66, 35, 10.1007/s002230050007
Rosenberg, 2000, Sinus grafting using platelet-rich plasma—initial case presentation, Pract Periodontics Aesthet Dent, 12, 843
Rozycki, 1996, Protein extraction and solubilization
Sampath, 1984, Importance of geometry of the extracellular matrix in endochondral bone differentiation, J Cell Biol, 98, 2192, 10.1083/jcb.98.6.2192
Schmid, 1984, Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells, FEBS Lett, 173, 48, 10.1016/0014-5793(84)81015-7
Shanaman, 2001, Localized ridge augmentation using GBR and platelet-rich plasma: case reports, Int J Periodontics Restorative Dent, 21, 345
Siebrecht, 2002, Platelet concentrate increases bone ingrowth into porous hydroxyapatite, Orthopedics, 25, 169, 10.3928/0147-7447-20020201-22
Stephan, 2000, Platelet-derived growth factor enhancement of a mineral-collagen bone substitute, J Periodontol, 71, 1887, 10.1902/jop.2000.71.12.1887
Urist, 1987, Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs, Clin Orthop, 295
Wada, 1998, Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells, Bone, 22, 479, 10.1016/S8756-3282(98)00039-8
Weibrich, 2002, Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count, J Craniomaxillofac Surg, 30, 97, 10.1054/jcms.2002.0285
Wozney, 1995, The potential role of bone morphogenetic proteins in periodontal reconstruction, J Periodontol, 66, 506, 10.1902/jop.1995.66.6.506
Yang, 2000, Activation of latent transforming growth factor-beta1 is induced by mannose 6-phosphate/insulin-like growth factor-II receptor, Wound Repair Regen, 8, 538, 10.1046/j.1524-475x.2000.00538.x
Yehualaeshet, 1999, Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36, Am J Pathol, 155, 841, 10.1016/S0002-9440(10)65183-8